These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 5560913)

  • 21. [Metabolic changes following glucose and tolbutamide loading in liver cirrhosis and their role in the pathogenesis of hepatogenic diabetes mellitus].
    Kopetz K; Wehrmann P
    Klin Wochenschr; 1970 Nov; 48(21):1265-76. PubMed ID: 5519414
    [No Abstract]   [Full Text] [Related]  

  • 22. [A method of studying insulin secretion in humans: the glucose stimulation test, followed by tolbutamide].
    Vague P; Ramahandridona G; Vialettes B
    Nouv Presse Med; 1976 Dec; 5(4):3001-4. PubMed ID: 794823
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Propranolol and hypoglycemic sulfonamides. Study on insulin secretion and blood sugar].
    Loubathières A; Mariani MM; Ribes G; Chapal J
    C R Seances Soc Biol Fil; 1971; 165(6):1393-7. PubMed ID: 4262051
    [No Abstract]   [Full Text] [Related]  

  • 24. Effect of long-term tolbutamide treatment on glucose tolerance and insulin secretion in maturity-onset diabetes without obesity.
    Lauvaux JP; Mandart G; Heymans G; Ooms HA
    Horm Metab Res; 1972 Mar; 4(2):58-62. PubMed ID: 5028221
    [No Abstract]   [Full Text] [Related]  

  • 25. Tolbutamide causes a modest increase in insulin secretion in cystic fibrosis patients with impaired glucose tolerance.
    Hinds A; Sheehan AG; Parsons HG
    Metabolism; 1995 Jan; 44(1):13-8. PubMed ID: 7854158
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preserved insulin response to tolbutamide in hepatocyte nuclear factor-1alpha mutation carriers.
    Sagen JV; Pearson ER; Johansen A; Spyer G; Søvik O; Pedersen O; Njølstad PR; Hattersley AT; Hansen T
    Diabet Med; 2005 Apr; 22(4):406-9. PubMed ID: 15787664
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Comparative studies of the oral and intravenous tolbutamide test. II. Determination of glucose, serum-insulin and serum-tolbutamide in normal young subjects].
    Berchtold P; Büber V; Meier V; Felber JP; Keiser G
    Diabetologia; 1971 Apr; 7(2):77-81. PubMed ID: 5581543
    [No Abstract]   [Full Text] [Related]  

  • 28. Elevated serum human growth hormone and decreased serum insulin in prediabetic males after intravenous tolbutamide and glucose.
    Boden G; Soeldner JS; Gleason RE; Marble A
    J Clin Invest; 1968 Apr; 47(4):729-39. PubMed ID: 5641614
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exaggerated intestinal glucagon and insulin responses in human subjects.
    Vance JE; Stoll RW; Fariss BL; Williams RH
    Metabolism; 1972 May; 21(5):405-12. PubMed ID: 4401389
    [No Abstract]   [Full Text] [Related]  

  • 30. A glucose-responsive insulinoma.
    Power L
    JAMA; 1969 Feb; 207(5):893-6. PubMed ID: 4303511
    [No Abstract]   [Full Text] [Related]  

  • 31. [Pancreatic insulin function in subjects having undergone gastrectomy].
    Fratino P; Mascetti P; Mascetti R
    Minerva Med; 1974 Oct; 65(69):3614-25. PubMed ID: 4418441
    [No Abstract]   [Full Text] [Related]  

  • 32. Failure of synalbumin to exhibit insulin antagonism in vivo.
    Davidson MB; Goodner CJ
    Diabetes; 1967 Jun; 16(6):386-94. PubMed ID: 6025265
    [No Abstract]   [Full Text] [Related]  

  • 33. A modified protocol for estimation of insulin sensitivity with the minimal model of glucose kinetics in patients with insulin-dependent diabetes.
    Finegood DT; Hramiak IM; Dupre J
    J Clin Endocrinol Metab; 1990 Jun; 70(6):1538-49. PubMed ID: 2189884
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glucose tolerance and insulin secretion in hyperthyroidism.
    Andersen OO; Friis T; Ottesen B
    Acta Endocrinol (Copenh); 1977 Mar; 84(3):576-87. PubMed ID: 320805
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of portacaval anastomosis on oral carbohydrate tolerance and on plasma insulin levels.
    Holdsworth CD; Nye L; King E
    Gut; 1972 Jan; 13(1):58-63. PubMed ID: 5060671
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Studies on the effect of various sulfonylureas during adrenergic blockade of the insulin secretion in man].
    Haslbeck M; Brauch K; Hepp KD; Mehnert H
    Verh Dtsch Ges Inn Med; 1971; 77():543-6. PubMed ID: 5005529
    [No Abstract]   [Full Text] [Related]  

  • 37. Secretion of glucagon and insulin in hypophysectomized rats: effect of tolbutamide.
    Dunbar JC; Walsh MF; Foà PP
    Horm Res; 1979; 11(2):81-91. PubMed ID: 383597
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Offspring of two diabetic parents: differential serum insulin responses to intravenous glucose and tolbutamide.
    Rojas L; Soeldner JS; Gleason RE; Kahn CB; Marble A
    J Clin Endocrinol Metab; 1969 Dec; 29(12):1569-79. PubMed ID: 4899852
    [No Abstract]   [Full Text] [Related]  

  • 39. Pharmacodynamic aspects of tolbutamide, glibenclamide, glibornuride and glisoxepide. I. Dose response relations and repeated administration in diabetic subjects.
    Haupt E; Köberich W; Beyer J; Schöffling K
    Diabetologia; 1971 Dec; 7(6):449-54. PubMed ID: 5004178
    [No Abstract]   [Full Text] [Related]  

  • 40. [Insulin and pro-insulin secretion following intravenous administration of tolbutamide, glisoxepide and glibenclamide].
    Hausmann L; Schumann G; Kaffarnik H
    Arzneimittelforschung; 1978; 28(1):83-6. PubMed ID: 415745
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.